how does difference in medical practice in japan and the rest of the world effect drug development?...

8
How does difference in medical practice in Japan and the rest of the world effect drug development? _ in the field of antidepressants _ and antipsychotics Mitsukuni Murasaki (Institute of CNS Pharmacology)

Upload: brook-taylor

Post on 20-Jan-2016

212 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: How does difference in medical practice in Japan and the rest of the world effect drug development? _ in the field of antidepressants _ and antipsychotics

  How does difference in medical practice in Japan and the rest of the world effect drug development?

_ in the field of antidepressants _and antipsychotics

Mitsukuni Murasaki(Institute of CNS Pharmacology)

Page 2: How does difference in medical practice in Japan and the rest of the world effect drug development? _ in the field of antidepressants _ and antipsychotics

Antidepressants (1)

Use of placebo

in any stage PossibleUSA, CanadaScandinavian countries

three armsRecommended

European countries

Impossible Germany, Japan

randomized withdrawal study (relapse/recurrence)

Necessary Europe

Recommended

Japan

Page 3: How does difference in medical practice in Japan and the rest of the world effect drug development? _ in the field of antidepressants _ and antipsychotics

Antidepressants (2)

Bridging study    - possible in Japan -・ same protocol・ same subject group・ same drug therapy

assessment of diagnostic criteriaDSM-ⅣICD-10

assessment of efficacy criteriaCGIHAM-DMADRS

Training for inter-rater reliability

Page 4: How does difference in medical practice in Japan and the rest of the world effect drug development? _ in the field of antidepressants _ and antipsychotics

Antidepressants (3)

Phase ⅠstudyPhase Ⅱa studyPhase Ⅱb studyPhase Ⅲ study    two comparative trials

  TCA  trazodon → SSRI    SNRI

Long-term study

Page 5: How does difference in medical practice in Japan and the rest of the world effect drug development? _ in the field of antidepressants _ and antipsychotics

Antipsychotics (1)

Use of placebo

Possible USA, Canada

ImpossibleEuropeJapan

Schizophrenia   -   Progressive and irreversible              the earlier, the better

Page 6: How does difference in medical practice in Japan and the rest of the world effect drug development? _ in the field of antidepressants _ and antipsychotics

Antipsychotics (2)

Bridging study (1) -difficult in Japan-assessment of diagnostic criteria

DSM-ⅣICD-10 paranoid

disorganized (hebephrenic)

schizo - affectiveassessment of efficacy criteria

CGIBPRSPANSS

assessment of adverse eventsEPS DIEPS

Simpson – AngusAkathisia Barnes

Training for inter-rater reliability

Page 7: How does difference in medical practice in Japan and the rest of the world effect drug development? _ in the field of antidepressants _ and antipsychotics

Antipsychotics (3)

Bridging study (2)

protocol

subject groupacute/acute exacerbation USAchronic Japan

method for drug therapymono therapy USAcombination therapy

Japan

Page 8: How does difference in medical practice in Japan and the rest of the world effect drug development? _ in the field of antidepressants _ and antipsychotics

Antipsychotics (4)

Phase ⅠstudyPhase Ⅱa studyPhase Ⅱb studyPhase Ⅲ study two comparative trials in Japan

haloperidolmosapramine → atypicals

(risperidone)Long-term study